Employer record · Emeryville, CA · FY2020–FY2026

Eureka Therapeutics, Inc.

    Certified LCAs
    3
    FY2024–FY2026
    USCIS approvals
    3
    0 new employment
    Denial rate
    0.0%
    FY2024–FY2026
    Median wage offered
    $142k
    certified LCAs

    Jobs not indexed yet

    Does Eureka Therapeutics, Inc. sponsor H-1B visas?

    Yes — by its record, Eureka Therapeutics, Inc. is a small-scale H-1B sponsor: it filed 3 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 3 USCIS H-1B petition approvals (0 for new employment). Its latest certified LCA in our data was decided Jun 9, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep) — 9 since FY2020; the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Eureka Therapeutics, Inc. certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2023100%
    FY2111100%
    FY2201100%
    FY233150%
    FY2401100%
    FY2632100%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Natural Sciences Managers 11-91212$142k
    Medical Scientists, Except Epidemiologists 19-10421$130k

    Most-filed job titles

    1. Senior Clinical Research Associate I2$142k
    2. Senior Scientist, Early Discovery1$130k

    LCAs per title and median wage offered.

    Where the jobs were

    1. California3 LCAs

    We haven't indexed Eureka Therapeutics' jobs yet

    We read jobs straight from employers' own career sites and haven't added Eureka Therapeutics' yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • EUREKA THERAPEUTICS INC (USCIS)
    • Eureka Therapeutics, Inc. (LCA)
    • EUREKA THERAPEUTICS, INC. (USCIS)

    Eureka Therapeutics, Inc. H-1B: questions people ask

    Does Eureka Therapeutics, Inc. sponsor H-1B visas?

    Yes — by its record, Eureka Therapeutics, Inc. is a small-scale H-1B sponsor: it filed 3 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 3 USCIS H-1B petition approvals (0 for new employment). Its latest certified LCA in our data was decided Jun 9, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Eureka Therapeutics, Inc. still sponsoring H-1B in 2026?

    Eureka Therapeutics, Inc. had 3 certified LCAs in FY2026 (Oct 2025–Sep 2026), more than the 0 in FY2025. The latest one in our data was decided Jun 9, 2026. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Eureka Therapeutics, Inc. get approved?

    USCIS recorded 3 approvals (0 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for Eureka Therapeutics, Inc. in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Eureka Therapeutics, Inc.?

    The median wage offered on Eureka Therapeutics, Inc.'s certified LCAs in FY2024–FY2026 was $142k a year. By job title: Senior Clinical Research Associate I $142k (2 LCAs) and Senior Scientist, Early Discovery $130k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Eureka Therapeutics, Inc. sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Natural Sciences Managers (2) and Medical Scientists, Except Epidemiologists (1).

    Where are Eureka Therapeutics, Inc.'s H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): California (3).

    Is Eureka Therapeutics, Inc. an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Eureka Therapeutics, Inc. have open jobs?

    We read jobs straight from employers' own career sites and haven't added Eureka Therapeutics' yet.